Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 2, 2009, Pages 412-418

  Macey, Tara A ^a   Bobeck, Erin N ^a   Hegarty, Deborah M ^b   Aicher, Sue A ^b   Ingram, Susan L ^a   Morgan, Michael M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CHLORNALTREXAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR CHANGE; CELL COMMUNICATION; CHRONIC DRUG ADMINISTRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME ACTIVATION; MALE; MICROINJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHINE; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70350440311     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.152157     Document Type: Article

References (39)

1. Asensio VJ, Miralles A, and García-Sevilla JA (2006) Stimulation of mitogenactivated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal. Eur J Pharmacol 539:49-56. (Pubitemid 43783513)
2. Bagley EE, Vaughan CW, and Christie MJ (1999) Inhibition by adenosine receptor agonists of synaptic transmission in rat periaqueductal grey neurons. J Physiol 516:219-225.
3. Bailey CP and Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68. (Pubitemid 40124536)
4. Belcheva MM, Clark AL, Haas PD, Serna JS, Hahn JW, Kiss A, and Coscia CJ (2005) Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 280:27662-27669. (Pubitemid 41076879)
5. Belcheva MM, Vogel Z, Ignatova E, Avidor-Reiss T, Zippel R, Levy R, Young EC, Barg J, and Coscia CJ (1998) Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem 70:635-645. (Pubitemid 28079352)
6. Berhow MT, Hiroi N, and Nestler EJ (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715. (Pubitemid 26251066)
7. Commons KG, Beck SG, Rudoy C, and Van Bockstaele EJ (2001) Anatomical evidence for presynaptic modulation by the delta opioid receptor in the ventrolateral periaqueductal gray of the rat. J Comp Neurol 430:200-208. (Pubitemid 32052657)
8. Ferrer-Alcón M, García-Fuster MJ, La Harpe R, and García-Sevilla JA (2004) Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts. J Neurochem 90:220-230.
9. Hack SP, Bagley EE, Chieng BC, and Christie MJ (2005) Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25:3192-3198.
10. Ingram SL, Macey TA, Fossum EN, and Morgan MM (2008) Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology 33:2494-2504.
11. Ingram SL, Vaughan CW, Bagley EE, Connor M, and Christie MJ (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 18:10269-10276. (Pubitemid 29016546)
12. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
13. Jacquet YF and Lajtha A (1976) The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Brain Res 103:501-513.
14. Lane DA and Morgan MM (2005) Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat. Brain Res 1047:65-71.
15. Ma W, Zheng WH, Powell K, Jhamandas K, and Quirion R (2001) Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 14:1091-1104. (Pubitemid 35463753)
16. Macey TA, Lowe JD, and Chavkin C (2006) Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J Biol Chem 281:34515-34524. (Pubitemid 46036659)
17. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pagès G, Valverde O, et al. (2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34:807-820. (Pubitemid 34628742)
18. Meyer PJ, Fossum EN, Ingram SL, and Morgan MM (2007) Analgesic tolerance to microinjection of the mu-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology 52:1580-1585.
19. Milne RJ and Gamble GD (1989) Habituation to sham testing procedures modifies tail-flick latencies: effects on nociception rather than vasomotor tone. Pain 39:103-107.
20. Mody N, Leitch J, Armstrong C, Dixon J, and Cohen P (2001) Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 502:21-24. (Pubitemid 32722053)
21. Morgan MM, Fossum EN, Levine CS, and Ingram SL (2006) Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol Biochem Behav 85:214-219.
22. Morgan MM, Tierney BW, and Ingram SL (2005) Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res 1059:173-178.
23. Moulédous L, Díaz MF, and Gutstein HB (2007) Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse. Pharmacol Biochem Behav 88:39-46.
24. Muller DL and Unterwald EM (2004) In vivo regulation of extracellular signalregulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 310:774-782.
25. Narita M, Ioka M, Suzuki M, Narita M, and Suzuki T (2002) Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neurosci Lett 324:97-100. (Pubitemid 34457814)
26. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, and Nestler EJ (1995) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15: 1285-1297.
27. Paxinos G and Watson SJ (2005) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
28. Pouysségur J and Lenormand P (2003) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270:3291-3299. (Pubitemid 35238027)
29. Rozenfeld R and Devi LA (2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J 21:2455-2465. (Pubitemid 47230675)
30. Schmidt H, Schulz S, Klutzny M, Koch T, Händel M, and Höllt V (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem 74:414-422. (Pubitemid 30012796)
31. Schulz S and Höllt V (1998) Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur J Neurosci 10:1196-1201. (Pubitemid 28375645)
32. Siuciak JA and Advokat C (1987) Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine. Brain Res 424:311-319.
33. 2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. Biochem Pharmacol 54:809-818.
34. Standifer KM and Pasternak GW (1997) G proteins and opioid receptor-mediated signalling. Cell Signal 9:237-248.
35. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311-317. (Pubitemid 38759861)
36. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298:865-872. (Pubitemid 32761897)
37. Thomas GM and Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173-183.
38. Tortorici V, Robbins CS, and Morgan MM (1999) Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav Neurosci 113:833-839. (Pubitemid 29426702)
39. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.